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Nosocomial
Dengue by
Mucocutaneous
Transmission
To the Editor: Wagner and col-
leagues report nosocomial dengue
transmitted by needlestick and note
that it is the fourth case of nosocomi-
al dengue to their knowledge (1). In
the same issue of Emerging Infectious
Diseases, Nemes and colleagues
report a separate case of nosocomial
dengue also transmitted by needle-
stick (2). Three other cases of nosoco-
mial dengue transmission by needle-
stick have previously been published
(3–5).
We have recently published a case
of nosocomial dengue infection that
was transmitted by mucocutaneous
exposure to blood from a febrile trav-
eler who had recently returned from
Peru (6). During phlebotomy, a
healthcare worker was splashed in the
face with the traveler’s blood. Both
the traveler and the healthcare worker
were subsequently found to have
dengue fever with dengue virus type
3. This route of infection is biologi-
cally plausible because infection
through mucosal surfaces (intranasal
and oral routes) has been shown pos-
sible for arboviruses (7). In our
review of the literature, we also found
a report of dengue virus transmission
by bone marrow transplantation (8).
Other cases of transmission of dengue
virus without a mosquito vector have
occurred in 5 reported instances of
infection in newborns as a result of
intrapartum or vertical transmission
from mother to child (9–12).
We agree that nosocomial trans-
mission may become more common
in temperate areas as more travelers
return home with acute dengue fever.
As Wagner and colleagues pointed
out, travelers visiting Southeast Asia
have the greatest risk of acquiring
dengue infections because of the high
endemicity of these viruses there. Our
report further illustrates the occur-
rence of dengue infection in the
Americas (13) and the risk for dengue
to travelers visiting this region.
Among 33 returned travelers with
dengue infection reported in the
United States in 1999 and 2000, 20
had acquired infection in the
Caribbean islands (12 cases) or
Central or South America (8 cases)
(14). Clinicians and laboratorians
should be alert to the possibility of
acquiring infection with a dengue
virus after needlestick or mucocuta-
neous blood exposure. The magnitude
of nosocomial transmission in
dengue-endemic areas is unknown
and more difficult to assess because
healthcare workers may be exposed to
dengue virus–infected mosquitoes
outside the clinical setting. 
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Barriers to
Creutzfeldt-Jakob
Disease Autopsies,
California
To the Editor: The recent article
by Louie et al. underscores a more
general disparity between the need for
autopsies in potential infectious dis-
ease deaths and our present national
capacity (1). In addition to confirming
Creutzfeldt-Jakob disease (CJD) and
allowing the differentiation of classic
and variant CJD, autopsies identify
previously undetected infections, dis-
cover causative organisms in unex-
plained infectious disease deaths, and
provide insights into the pathogenesis